GNG12 and cancer: On this concept a recent study reported that silencing the transducer and transmembrane-signal regulator (GNG12) gene leads to the downregulation of the PD-L1 gene transcription, thus, GNG12 can be suggested as a cancer risk factor and can be considered as a possible immunotherapy target [12].